Cellosaurus logo
expasy logo

Cellosaurus TFK-1 (CVCL_2214)

[Text version]
Cell line name TFK-1
Synonyms TFK1
Accession CVCL_2214
Resource Identification Initiative To cite this cell line use: TFK-1 (RRID:CVCL_2214)
Comments Part of: Biliary tract cancer cell line atlas.
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Population: Japanese.
Doubling time: ~37 hours (Note=At 40th passage) (PubMed=8693487); ~40 hours (DSMZ=ACC-344).
Omics: Deep exome analysis.
Omics: Transcriptome analysis by RNAseq.
Misspelling: TFKK-1; PubMed=22490663; Note=In supplementary figure 2.
Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
Sequence variations
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Homozygous (DepMap=ACH-001673).
Disease Cholangiocarcinoma (NCIt: C4436)
Cholangiocarcinoma (ORDO: Orphanet_70567)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_QZ53 (RTFK-1)
Sex of cell Male
Age at sampling 63Y
Category Cancer cell line
STR profile Source(s): DepMap=ACH-001673; DSMZ=ACC-344; RCB=RCB2537; TKG=TKG 0367

Markers:
AmelogeninX,Y
CSF1PO10
D2S133818,22
D3S135817,18
D5S8189,12
D7S82010 (DSMZ=ACC-344)
10,11 (DepMap=ACH-001673; RCB=RCB2537; TKG=TKG 0367)
D8S117913,14
D13S31714
D16S5399
D18S5116
D19S43314,15
D21S1130
FGA20,23
Penta D13,14
Penta E5,18 (DepMap=ACH-001673)
18 (DSMZ=ACC-344)
TH016
TPOX8
vWA14,17

Run an STR similarity search on this cell line
Publications

PubMed=8693487; DOI=10.1620/tjem.177.61
Saijyo S., Kudo T., Suzuki M., Katayose Y., Shinoda M., Muto T., Fukuhara K., Suzuki T., Matsuno S.
Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.
Tohoku J. Exp. Med. 177:61-71(1995)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=22490663; DOI=10.1016/j.bbrc.2012.03.122
Saiki Y., Yoshino Y., Fujimura H., Manabe T., Kudo Y., Shimada M., Mano N., Nakano T., Lee Y., Shimizu S., Oba S., Fujiwara S., Shimizu H., Chen N., Nezhad Z.K., Jin G., Fukushige S., Sunamura M., Ishida M., Motoi F., Egawa S., Unno M., Horii A.
DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.
Biochem. Biophys. Res. Commun. 421:98-104(2012)

CLPUB00275
Zach S., Birgin E., Ruckert F.
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442; PMCID=PMC5458737
Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C., Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K., Greninger P., McDermott U., Garnett M.J., Jenkins R.L., Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y., Goyal L., Ferrone C.R., Zhu A.X.-X., Joung J.K., Shokat K.M., Benes C.H., Bardeesy N.M.
Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.
Cancer Discov. 6:727-739(2016)

PubMed=31077409; DOI=10.1002/hep.30704
Sittithumcharee G., Suppramote O., Vaeteewoottacharn K., Sirisuksakun C., Jamnongsong S., Laphanuwat P., Suntiparpluacha M., Matha A., Chusorn P., Buraphat P., Kakanaporn C., Charngkaew K., Silsirivanit A., Korphaisarn K., Limsrichamrern S., Tripatara P., Pairojkul C., Wongkham S., Sampattavanich S., Okada S., Jirawatnotai S.
Dependency of cholangiocarcinoma on cyclin D-dependent kinase activity.
Hepatology 70:1614-1630(2019)

PubMed=32899426; DOI=10.3390/cancers12092510; PMCID=PMC7565451
Scherer D., Davila-Lopez M., Goeppert B., Abrahamsson S., Gonzalez Silos R., Nova I., Marcelain K., Roa J.C., Ibberson D., Umu S.U., Rounge T.B., Roessler S., Lorenzo-Bermejo J.
RNA sequencing of hepatobiliary cancer cell lines: data and applications to mutational and transcriptomic profiling.
Cancers (Basel) 12:2510.1-2510.14(2020)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)

PubMed=39026794; DOI=10.1101/2024.07.04.601970; PMCID=PMC11257448
Vijay V., Karisani N., Shi L., Hung Y.-H., Vu P., Kattel P., Kenney L., Merritt J., Adil R., Wu Q.-B., Zhen Y.-L., Morris R., Kreuzer J., Kathiresan M., Herrera Lopez X.I., Ellis H., Gritti I.G., Lecorgne L., Farag I., Popa A., Shen W., Kato H., Xu Q., Balasooriya E.R., Wu M.-J., Chaturantabut S., Kelley R.K., Cleary J.M., Lawrence M.S., Root D.E., Benes C.H., Deshpande V., Juric D., Sellers W.R., Ferrone C.R., Haas W., Vazquez F., Getz G., Bardeesy N.M.
Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets.
bioRxiv 2024:07.04.601970-07.04.601970(2024)

Cross-references
Cell line collections (Providers) DSMZ; ACC-344
RCB; RCB2537
TKG; TKG 0367
Cell line databases/resources CLO; CLO_0009330
CLO; CLO_0050010
cancercelllines; CVCL_2214
Cell_Model_Passport; SIDM01462
DepMap; ACH-001673
DSMZCellDive; ACC-344
Biological sample resources BioSample; SAMN03471922
BioSample; SAMN03473356
Encyclopedic resources Wikidata; Q54972205
Polymorphism and mutation databases Cosmic; 927187
Cosmic; 1122354
Cosmic; 1373550
Cosmic; 2674051
Entry history
Entry creation04-Apr-2012
Last entry update19-Dec-2024
Version number29